EAS 92nd Congress Highlights
Triglyceride-focused highlights from the 92nd Annual Congress of the European Atherosclerosis Society (26-29 May 2024, Lyon, France, and online) included recently published human genetic studies supporting the potential of ANGPTL3/4 inhibition in the prevention of atherosclerotic cardiovascular disease (ASCVD), final results from the ARCHES-2 and MUIR trials of the effects of ANGPTL3 and ApoC3 targeting […]
Read More > EAS 92nd Congress Highlights